RBEDX | RCDTX | RBEDX / RCDTX | |
Total Expense Ratio | 1.11 | 0.95 | 117% |
Annual Report Gross Expense Ratio | 1.11 | 0.95 | 117% |
Fund Existence | 11 years | 18 years | - |
Gain YTD | 2.026 | 2.076 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 32.1B | 32.1B | 100% |
Annual Yield % from dividends | 2.06 | 2.18 | 95% |
Returns for 1 year | 6.09 | 6.31 | 96% |
Returns for 3 years | 11.37 | 11.87 | 96% |
Returns for 5 years | 20.84 | 21.75 | 96% |
Returns for 10 years | 28.09 | 30.43 | 92% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HDOGX | 13.44 | N/A | N/A |
Hennessy Total Return Investor | |||
PCVAX | 10.55 | N/A | N/A |
Virtus NFJ Small-Cap Value A | |||
MNOPX | 30.25 | N/A | N/A |
Morgan Stanley Inst International Opp R6 | |||
PACOX | 54.73 | N/A | N/A |
T. Rowe Price U.S. Equity Research Adv | |||
VMVFX | 16.08 | N/A | N/A |
Vanguard Global Minimum Volatility Inv |